SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15088)2/14/1998 6:24:00 PM
From: Hippieslayer  Read Replies (1) | Respond to of 32384
 
Re: If human breast cancer data is even close to the rat data.....

If and when LGND presents data that 60+% of women had significant shrinkage or total remission of their malignant breast cancer due to targretin, LGND will be plastered on every magazine (TIME, NEWSWEEK, etc) and on every nightly news program. That will surely help the stock gain at least a point or two. :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News